Pricing Strategy for a New Pharmaceutical Drug

Only available on StudyMode
  • Download(s) : 228
  • Published : March 17, 2012
Open Document
Text Preview
Pharmaceutical Manufacturing – Economics Perspective
Pharmaceutical industry is unique in the economy since it is a manufacturing industry but is fundamentally based in research and development. The US pharmaceutical industry is an international leader in drug innovation. US produced more new molecular entities, both chemical and biological, compared to Europe and Japan. The United States also leads, by far, Europe and Japan in the number for new Patents filed for pharmaceuticals. The United States accounts for almost half of the global pharmaceutical market, with $300 billion in annual sales (2006) followed by the EU and Japan. Economics behind a new drug price

Like every other manufacturing companies, pharmaceutical companies aim to manufacture products that must be sold for a profit in order for the company to survive and grow. The difference lies in the product they sell affecting their consumers’ health and life directly. This makes the business risky. Without a new discover of a ‘blockbuster’ drug every few years, the drug company survival is at risk. For instance, only one out of every ten thousand discovered compounds actually becomes an approved drug for sale. Much expense is incurred in the early phases of development of compounds that will not become approved drugs. In addition, it takes about 7 to 10 years and an average cost of 500 million dollars to develop each new drug. This money is spent before the FDA approves the drug, and if the drug is not approved, the company loses the money. These expenses must be covered by the revenue from compounds that successfully become approved drugs. Moreover, only 3 out of every 20 approved drugs bring in sufficient revenue to cover their developmental costs, and only 1 out of every 3 approved drugs generates enough money to cover the development costs of previous failures. Below we go in the different aspects of the spending involved in the drug company’s lifecycle. Research and Development

Numerous studies...
tracking img